Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing detailed study content with a minimal error screen and a Home link. This indicates an access issue that prevents users from viewing the trial record as intended.SummaryDifference19%

- Check10 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 in the Study Documents section, indicating an updated protocol/documentation. This change reflects a newer version of the study protocol and related documents linked on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision label was updated to v3.6.6, signaling a minor metadata/patch update to the page without changes to the study details.SummaryDifference0.0%

- Check31 days agoChange DetectedAn NIH grant/contract identifier for 2018 was added to the study's list of identifiers, indicating NIH support for the trial.SummaryDifference0.0%

- Check38 days agoChange DetectedThe Plain Language Summary section has been removed from the Study Details page, eliminating the lay-friendly overview of the trial.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing Revision: v3.6.4. This marks a minor update to the page content/version of the study record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.